GLP-3R (Retatrutide) is a triple agonist peptide researched for its simultaneous activation of GLP-1, GIP, and glucagon receptors. Preclinical studies investigate its potential for superior metabolic regulation, weight management, and glycemic control compared to single or dual receptor agonists.
